In Silico TRials guide optimal stratification of ATrIal FIbrillation patients to Catheter Ablation and pharmacological medicaTION: the i-STRATIFICATION study
Europace · 03.06.2024 · 26 (6)
DOI: 10.1093/europace/euae150 ↗Kurz gefasst
Fachartikel in der Zeitschrift Europace, online erschienen am 13.06.2024. Verfasst von Albert Dasí und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Computer Science, University of Oxford, Wolfson Building, Parks Road, Oxford OX1 3QD, UK. Hauptthemen laut MEDLINE: Atrial Fibrillation, Catheter Ablation, Pulmonary Veins, Anti-Arrhythmia Agents. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CompBioMed and CompBiomed2 Centre of Excellence in Computational Biomedicine, Oxford BHF Centre of Research Excellence, PRACE.
Abstract (Originalsprache)
Aims
Patients with persistent atrial fibrillation (AF) experience 50% recurrence despite pulmonary vein isolation (PVI), and no consensus is established for secondary treatments. The aim of our i-STRATIFICATION study is to provide evidence for stratifying patients with AF recurrence after PVI to optimal pharmacological and ablation therapies, through in silico trials. Methods and results A cohort of 800 virtual patients, with variability in atrial anatomy, electrophysiology, and tissue structure (low-voltage areas, LVAs), was developed and validated against clinical data from ionic currents to electrocardiogram. Virtual patients presenting AF post-PVI underwent 12 secondary treatments. Sustained AF developed in 522 virtual patients after PVI. Second ablation procedures involving left atrial ablation alone showed 55% efficacy, only succeeding in the small right atria (<60 mL). When additional cavo-tricuspid isthmus ablation was considered, Marshall-PLAN sufficed (66% efficacy) for the small left atria (<90 mL). For the bigger left atria, a more aggressive ablation approach was required, such as anterior mitral line (75% efficacy) or posterior wall isolation plus mitral isthmus ablation (77% efficacy). Virtual patients with LVAs greatly benefited from LVA ablation in the left and right atria (100% efficacy). Conversely, in the absence of LVAs, synergistic ablation and pharmacotherapy could terminate AF. In the absence of ablation, the patient’s ionic current substrate modulated the response to antiarrhythmic drugs, being the inward currents critical for optimal stratification to amiodarone or vernakalant.
Conclusion
In silico trials identify optimal strategies for AF treatment based on virtual patient characteristics, evidencing the power of human modelling and simulation as a clinical assisting tool.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Computer Science, University of Oxford, Wolfson Building, Parks Road, Oxford OX1 3QD, UK.
- Institute of Biomedical Engineering, Karlsruhe Institute of Technology (KIT), Karlsruhe, Germany.
- Department of Cardiology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
- Department for Human Development and Health, University of Southampton, Southampton, UK.
- Oxford Centre for Clinical Magnetic Resonance Research, Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
- Departamento de Ciência da Computação, Universidade Federal de São João del Rei, São João del Rei, MG, Brazil.
ORCID-Profile: Albert Dasí, Claudia Nagel, Michael T B Pope, Rohan S Wijesurendra, Timothy R Betts, Rafael Sachetto, Axel Loewe, Alfonso Bueno-Orovio
Förderung
- CompBioMed and CompBiomed2 Centre of Excellence in Computational Biomedicine
- Oxford BHF Centre of Research Excellence
- PRACE
- European Union's Horizon 2020
- Marie Skłodowska-Curie
- Wellcome Trust
- Wellcome Trust Senior Fellowship in Basic Biomedical Sciences
- Oxford Biomedical Research Centre and the CompBiomedX EPSRC-funded project
Zitieren
APA
Dasí, A., Nagel, C., Pope, M. T. B., Wijesurendra, R. S., Betts, T. R., Sachetto, R., Loewe, A., Bueno-Orovio, A., & Rodriguez, B. (2024). In Silico TRials guide optimal stratification of ATrIal FIbrillation patients to Catheter Ablation and pharmacological medicaTION: the i-STRATIFICATION study. Europace, 26(6). https://doi.org/10.1093/europace/euae150
Vancouver
Dasí A, Nagel C, Pope MTB, Wijesurendra RS, Betts TR, Sachetto R, et al. In Silico TRials guide optimal stratification of ATrIal FIbrillation patients to Catheter Ablation and pharmacological medicaTION: the i-STRATIFICATION study. Europace. 2024;26(6). doi:10.1093/europace/euae150
BibTeX
@article{Das2024,
author = {Dasí, Albert and Nagel, Claudia and Pope, Michael T B and Wijesurendra, Rohan S and Betts, Timothy R and Sachetto, Rafael and Loewe, Axel and Bueno-Orovio, Alfonso and Rodriguez, Blanca},
title = {In Silico TRials guide optimal stratification of ATrIal FIbrillation patients to Catheter Ablation and pharmacological medicaTION: the i-STRATIFICATION study},
journal = {Europace},
year = {2024},
volume = {26},
number = {6},
doi = {10.1093/europace/euae150}
}
EUVIMED